Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes-Reference-Cited by-同舟云学术

Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes

Published:2022-02 Issue: Volume:234 Page:223-234
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Beykin Gala^ORCID,Stell Laurel^ORCID,Halim Muhammad Sohail^ORCID,Nuñez Mariana,Popova Lilia,Nguyen Bac T.^ORCID,Groth Sylvia L.^ORCID,Dennis Amy,Li Zhongqiu,Atkins Melissa^ORCID,Khavari Tom,Wang Sophia Y.^ORCID,Chang Robert^ORCID,Fisher Ann C.,Sepah Yasir J.,Goldberg Jeffrey L.^ORCID

Publisher

Elsevier BV

Subject

Ophthalmology

Reference51 articles.

1. Destruction of the sympathetic ganglia in mammals by an antiserum to a nerve-growth protein;Levi-Montalcini;Proc Natl Acad Sci U S A.,1960

2. Exploring serum levels of brain derived neurotrophic factor and nerve growth factor across glaucoma stages;Oddone;PLoS One,2017

3. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats;Quigley;Invest Ophthalmol Vis Sci,2000

4. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma;Pease;Invest Ophthalmol Vis Sci,2000

5. Nerve growth factor: early studies and recent clinical trials;Rocco;Curr Neuropharmacol,2018

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Nerve Growth Factor in Treating Neurotrophic Keratitis Patients: A Meta-Analysis;British Journal of Hospital Medicine;2024-08-30

2. Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments;Progress in Retinal and Eye Research;2024-05

3. Molecular pathways in experimental glaucoma models;Frontiers in Neuroscience;2024-03-18

4. Enhanced neuroprotective activity of ophthalmic delivered nerve growth factor conjugated with cell penetrating peptide against optic nerve injury;Journal of Drug Targeting;2023-12-28

5. A Review of Rattlesnake Venoms;Toxins;2023-12-19